Avinger-about-hero-mobile Avinger-about-hero-tablet
about_avinger

We’re radically changing the way
vascular disease is treated

Our Story

Vascular disease isn’t going away. Real people continue to fight the progression and complications that result from PAD. We’ve won many battles but the war goes on and we don’t take our responsibility to create change lightly. As our company ages, many of our ideas have become realities yet we still lie awake at night devising plans to do more. We know many are counting on us to do more. We continue to be an ordinary group of individuals trying to achieve the extraordinary. For this opportunity we remain extremely blessed.

Leadership

  • Jeff2
    Jeffrey M. Soinski Chief Executive Officer
  • 0023
    Mark Weinswig Chief Financial Officer
  • Himanshu2
    Himanshu Patel Chief Technology Officer
  • Phil2
    Phil Preuss Vice President, Marketing & Business Operations
  • 000
    Corey Gibbs Vice President, Sales
  • Lawson 222
    Thomas Lawson, PhD Vice President, Clinical & Regulatory Affairs
  • Golzar 2
    Jaafer Golzar, MD, FACC, FSCAI Chief Medical Officer
SEE MORE
  • Jeff2
    Jeffrey M. Soinski Chief Executive Officer
  • 222
    James G. Cullen Director
  • 221
    James B. McElwee Director
  • 4
    Donald A. Lucas Director
SEE MORE
banner-img03

Careers

Join us as we develop powerful new weapons in the fight against Peripheral Artery Disease.

SEE OUR OPEN POSITIONS

Avinger in the News

For media outreach and inquiries, please contact press@avinger.com to tell us your story.